Inpharma Weekly

, Volume 1550, Issue 1, pp 17–17 | Cite as

R-GIFOX promising for recurrent or refractory aggressive NHL

Clinical study
  • 5 Downloads

Keywords

Stem Cell Lymphoma Pilot Study Gemcitabine Partial Response 

Copyright information

© Adis International Ltd 2006

Personalised recommendations